MB  Piper Sandler Merchant Banking

https://www.pipersandler.com/





     Office Locations:

800 Nicollet Mall
Minneapolis, MN 55402

 

Stages:

  • Expansion
  • Middle Market


 

Industries:

  • Business Services
  • Consumer Products & Services
  • Energy & Clean Tech
  • Financial Services
  • Information Technology
  • Life Sciences & Healthcare
  • Manufacturing & Industrial
  • Retail & Restaurant
  • Software & Internet

  •  

    Description:

    Piper Sandler Merchant Banking (PSMB) is a part of the asset management business of Piper Sandler and operates as the private equity arm of the firm. PSMB is supported by Piper Sandler capital and that of distinguished non-affiliated limited partners. Piper Sandler Merchant Banking focuses on growth equity investments within the industry sectors covered by Piper Sandler equity research and investment banking experts: Healthcare, Technology, Business Services, Financial Technology & Services, Consumer, Energy, Chemicals & Materials. The firm is focused on investments in equity and equity-linked securities that finance company growth. Piper also invests in recapitalizations, secondary stock purchases and change of control transactions.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Bob Rinek Managing Director
    John Gast Vice President
    Ted Christianson Managing Director
    Tom Schnettler Managing Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      09/23/2021


      Elligo Health Research


      TX


      $135,000,000


      Series E


      06/24/2021


      Graylog


      TX


      $18,000,000


      Growth


     

    Portfolio companies include:


      Cafe Rio
        web link


      Clinicient
        web link


      Elligo Health Research
        web link


      Foodsby
        web link


      Graylog
        web link


      Gutcheck
        web link


      Hemasource
        web link


      MicroStar


      Sapphire Digital


      StriVectin
        web link


      Xenex Disinfection Services


     

    Recent News: